ISRCTN57719133已完成未知
Visual outcomes using an enhanced UV protected light adjustable lens in patients with previous LASIK and/or PRK
orth Suburban Eye Specialists0 个研究点目标入组 40 人开始时间: 2023年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37954910/ (added 20/11/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients who receive the ActivShield LAL with their cataract surgery
- •2. Have previous history of LASIK and/or PRK
- •3. Have pupil dilation of 6.5 mm or greater
- •4. Age between 40-90 years
排除标准
- •Patients with retinal or macular disease, clinically significant corneal abnormalities, corneal scarring, or ectasia were excluded from the study.
研究者
相似试验
招募中
不适用
Analysis of protective effects of a new UV device system for peritonitis in PD patients.End-Stage Renal Disease (ESRD)JPRN-UMIN000013942agoya University230
已完成
不适用
Effectivity of using a low-dose UVB lighting solution to maintain healthy vitamin D levelsNutritional, Metabolic, EndocrineVitamin D deficiencyISRCTN47902923Signify (Netherlands)28
终止
1 期
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin ConditionsPsoriasisMycosis FungoidesDermatosesStretch MarksAtopic DermatitisUrticariaAlopeciaNCT00129415University of Michigan28
已完成
不适用
Feasibility study of using blue-light blocking glasses to improve quality of life for cancer patientsAdvanced or metastatic cancerCancerISRCTN16219928Block Center for Integrative Cancer Treatment30
已完成
不适用
Efficacy of a food supplement in protecting the skin from sun and agingMild-to-moderate skin agingSkin and Connective Tissue DiseasesISRCTN89244753BIONAP srl110